跳至主要内容
临床试验/NL-OMON56237
NL-OMON56237已完成不适用

Amino acid concentrations in serum after intake of plant based protein sources - Plantino I and II

utricia Research0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Age >= 18 and <= 70 years
  • 2. Body Mass Index (BMI) >= 18.5 and <= 27.0 kg/m2
  • 3. Written informed consent
  • 4. Willingness and ability to comply with the protocol
  • 5. Judged by the Investigator to be in good health

排除标准

  • 1. Any gastrointestinal (GI) disease or surgery that may interfere with GI
  • function and/or protein metabolism, including but not limited to
  • phenylketonuria, pancreatitis, short bowel syndrome, celiac disease, Crohn*s
  • disease, in the opinion of the Investigator
  • 2. Known renal or hepatic diseases that may interfere with protein metabolism,
  • including but not limited to acute hepatitis, chronic liver disease, nephritis,
  • cystinuria, chronic kidney disease, in the opinion of the Investigator
  • 3. Use of systemic medication within the past 3 weeks prior to screening which
  • in the opinion of the Investigator may influence gastric acid production and/or
  • gastrointestinal motility or function and/or protein metabolism (for example:
  • antibiotics, anticonvulsants, prokinetics, antacids, opioid analgesics,
  • anticoagulants, corticosteroids, laxatives, growth hormone, testosterone,
  • immunosuppressants, or insulin).
  • 4. Allergy to soy, pea and/or cow*s milk protein
  • 5. Adherence to a weight loss program
  • 6. Current eating disorder, e.g. anorexia nervosa or bulimia
  • 7. Known pregnancy and/or lactation
  • 8. Current smoking or stopped smoking for < 1 month prior to screening (except
  • for incidental smoking of <= 3 cigarettes/cigars/pipes per week on average in
  • the last month prior to screening)
  • 9. Average alcohol use of > 21 glasses per week for men or > 14 glasses per
  • week for women (on average during the last 6 months prior to screening)
  • 10. Drug or medicine abuse in opinion of the investigator
  • 11. Any known bleeding disorder
  • 12. Known difficulties with placement of and/or blood drawings from a cannula
  • 13. Active participation in any other study with investigational or marketed
  • products concomitantly or within 4 weeks prior to screening
  • 14. Major medical or major surgical event requiring hospitalization within the
  • preceding 3 months and/or scheduled in the period of study participation
  • 15. Investigator*s uncertainty about the willingness or ability of the subject
  • to comply with the protocol requirements
  • 16. Employees of Nutricia Research and/or their family members or relatives

研究者

发起方
utricia Research

相似试验